BIOTALYS NV (BTLS.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:BTLS • BE0974386188

3.29 EUR

+0.04 (+1.23%)

Last: Jan 30, 2026, 07:00 PM

Fundamental Rating

Overall BTLS gets a fundamental rating of 2 out of 10. We evaluated BTLS against 71 industry peers in the Chemicals industry. The financial health of BTLS is average, but there are quite some concerns on its profitability. BTLS is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

BTLS had negative earnings in the past year.
BTLS had a negative operating cash flow in the past year.
BTLS had negative earnings in each of the past 5 years.
BTLS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

BTLS's Return On Assets of -51.18% is on the low side compared to the rest of the industry. BTLS is outperformed by 94.37% of its industry peers.
BTLS's Return On Equity of -74.88% is on the low side compared to the rest of the industry. BTLS is outperformed by 90.14% of its industry peers.

		Industry Rank	Sector Rank
ROA	-51.18%
ROE	-74.88%
ROIC	N/A

ROA(3y)-45.95%

ROA(5y)-38.32%

ROE(3y)-62.54%

ROE(5y)-51.65%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BTLS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, BTLS has more shares outstanding
BTLS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BTLS has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 6.12 indicates that BTLS is not in any danger for bankruptcy at the moment.
BTLS has a Altman-Z score of 6.12. This is amongst the best in the industry. BTLS outperforms 92.96% of its industry peers.
BTLS has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
BTLS has a Debt to Equity ratio of 0.16. This is in the better half of the industry: BTLS outperforms 74.65% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.16
Debt/FCF	N/A
Altman-Z	6.12

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

BTLS has a Current Ratio of 3.61. This indicates that BTLS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BTLS (3.61) is better than 92.96% of its industry peers.
BTLS has a Quick Ratio of 3.61. This indicates that BTLS is financially healthy and has no problem in meeting its short term obligations.
BTLS has a Quick ratio of 3.61. This is amongst the best in the industry. BTLS outperforms 95.77% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.61
Quick Ratio	3.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BTLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.48%, which is quite good.

EPS 1Y (TTM)19.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-7.58%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 0.29% on average over the next years.
BTLS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.43% yearly.

EPS Next Y1.76%

EPS Next 2Y15.09%

EPS Next 3Y0.29%

EPS Next 5YN/A

Revenue Next Year-52%

Revenue Next 2Y3.92%

Revenue Next 3Y10.43%

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BTLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BTLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.